A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.

被引：0
|
作者：
Papadopoulos, K
Mendelson, D
Preston, GG
Lopez, AM
Ricart, AD
Schwartz, G
Needle, MN
Gordon, MS
机构：
[1] Inst Drug Dev, San Antonio, TX USA
[2] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[3] Arizona Canc Ctr, Scottsdale, AZ USA
[4] Brooke Army Med Ctr, San Antonio, TX USA
[5] Celgene, Summit, NJ USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9116S / 9116S
页数：1
相关论文
共 50 条
  • [41] Phase I study of pemetrexed and sorafenib in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Shafer, Danielle A.
    Roberts, John D.
    Geyer, Charles E.
    Dent, Paul
    Moran, Richard
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Wan, Wen
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] A Phase I trial of weekly docetaxel and topotecan for solid tumors
    Lim, Wan Teck
    Baggstrom, Maria Q.
    Read, William
    Fracasso, Paula M.
    Govindan, Ramaswamy
    ACTA ONCOLOGICA, 2008, 47 (02) : 311 - 315
  • [43] A phase I dose finding study of weekly, sequential docetaxel (Doc) followed by flavopiridol (F) in patients with advanced solid tumors
    Rathkopf, D
    Fornier, M
    Shah, M
    Kortmansky, J
    O'Reilly, E
    King, A
    Winkelmann, J
    Kelsen, DP
    Olsen, S
    Schwartz, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 213S - 213S
  • [44] Phase I clinical and pharmacology study of the novel epothilone BMS-247550 given weekly in patients with advanced solid tumors.
    Awada, A
    Burris, H
    De Valeriola, D
    Hendlisz, A
    Huart, A
    Gil, T
    Jones, S
    Martin, C
    Crabeels, D
    Litwin, V
    Damle, B
    Moerman, C
    Piccart, M
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3810S - 3810S
  • [45] A phase I study of SB-408075 administered as a single intravenous infusion once weekly in patients with advanced solid tumors.
    Helft, PR
    Schilsky, RL
    Kindler, HL
    Bertucci, D
    Dewitte, MH
    Martino, HK
    Friedman, CJ
    Erickson, JC
    Lambert, JM
    Ratain, J
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3786S - 3786S
  • [46] Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
    Tan, Antoinette R.
    Dowlati, Afshin
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Nishioka, Jennifer
    Fang, Lei
    Hodge, Jeffrey P.
    Gainer, Shelby D.
    Arumugham, Thangam
    Suttle, A. Benjamin
    Dar, Mohammed M.
    Lager, Joanne J.
    Burris, Howard A., III
    ONCOLOGIST, 2010, 15 (12): : 1253 - 1261
  • [47] PX-866 and docetaxel in patients with advanced solid tumors.
    Jimeno, Antonio
    Senzer, Neil N.
    Rudin, Charles M.
    Ma, Wen Wee
    Halmos, Balazs
    Schnadig, Ian D.
    Levy, Benjamin
    Hausman, Diana Felice
    Peterson, Scott
    Walker, Luke N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] A phase I trial of bexarotene and docetaxel in patients with advanced solid tumors
    Malik, S. M.
    Marshall, J. L.
    Ramzi, P.
    Deeken, J. F.
    Pishvaian, M. J.
    Hwang, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors
    Tsao, AS
    Shin, DM
    Palmer, JL
    Lee, JS
    Glisson, BS
    CANCER, 2004, 100 (10) : 2240 - 2245
  • [50] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Papadopoulos, Kyriakos P.
    Adewoye, Adeboye H.
    Hunter, John
    Ramsey, Denise
    ElNaggar, Adam
    Patnaik, Amita
    Vaena, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
12345